Popanda O, Thielmann H W
German Cancer Research Center, Heidelberg.
Carcinogenesis. 1992 Dec;13(12):2321-8. doi: 10.1093/carcin/13.12.2321.
Fifteen specific inhibitors of DNA topoisomerases I and II were used to elucidate whether these enzymes participate in the excision repair of UV-induced DNA damage, monitoring DNA repair synthesis in confluent saponin-permeabilized human fibroblasts. To achieve a sufficient degree of accuracy dose--response experiments were performed, analysed by linear regression, and the concentrations at which repair activity was reduced to 50% were calculated and designated K50. Camptothecin, a specific inhibitor of topoisomerase I did not markedly diminish DNA repair synthesis. Similarly, when combined with topoisomerase II inhibitors [nalidixic acid, oxolinic acid, 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucop yra noside) (etoposide), 4'-demethylepipodophyllotoxin-thenylidene-beta-D-glucoside (teniposide), 1,4-dihydroxy-5,8-bis ((2-[(2-hydroxyethyl)amino]ethyl)amino)-9,10-anthracenedione (mitoxantrone), 5-(N-phenyl-carboxamido)-2-thiobarbituric acid (merbarone) or 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA)], it did not lower K50 values determined for topoisomerase II-specific drugs in separate experiments. The effects observed can be classified according to the mechanism of action the inhibitors exhibit. (i) Novobiocin and coumermycin, inhibitors of the ATPase subunit of topoisomerase II, completely reduced DNA repair synthesis. (ii) Inhibition of repair was also found for ethidium bromide, quinacrine and distamycin, drugs known to modify the DNA substrate by intercalation or binding to the DNA minor groove. (iii) Inhibitors acting through intercalation and, simultaneously, binding to the cleavable DNA-topoisomerase complex (m-AMSA, mitoxantrone, doxorubicin and daunorubicin) also suppressed reparative DNA synthesis. (iv) Only small effects were observed for etoposide, nalidixic acid and oxolinic acid, whereas teniposide caused marked inhibition of DNA repair synthesis. (v) Merbarone, a novel type of topoisomerase II inhibitor, blocked UV-induced DNA repair drastically. The results are best explained by assuming that in UV-irradiated human fibroblasts the 180 kDa form of topoisomerase II is the main target enzyme for inhibitors which suppressed DNA excision repair and that this isozyme is involved in steps preceding repair-specific DNA incision.
使用15种DNA拓扑异构酶I和II的特异性抑制剂,通过监测汇合的皂角苷通透化人成纤维细胞中的DNA修复合成,来阐明这些酶是否参与紫外线诱导的DNA损伤的切除修复。为达到足够的准确度,进行了剂量反应实验,通过线性回归分析,计算出修复活性降低至50%时的浓度并命名为K50。拓扑异构酶I的特异性抑制剂喜树碱并未显著减少DNA修复合成。同样,当与拓扑异构酶II抑制剂[萘啶酸、恶喹酸、4'-去甲基表鬼臼毒素-9-(4,6-O-亚乙基-β-D-吡喃葡萄糖苷)(依托泊苷)、4'-去甲基表鬼臼毒素-亚甲叉基-β-D-葡萄糖苷(替尼泊苷)、1,4-二羟基-5,8-双((2-[(2-羟乙基)氨基]乙基)氨基)-9,10-蒽二酮(米托蒽醌)、5-(N-苯基-甲酰胺基)-2-硫代巴比妥酸(美巴龙)或4'-(9-吖啶基氨基)甲磺酰间茴香胺(m-AMSA)]联合使用时,它并未降低在单独实验中针对拓扑异构酶II特异性药物测定的K50值。观察到的效应可根据抑制剂表现出的作用机制进行分类。(i) 拓扑异构酶II的ATP酶亚基抑制剂新生霉素和香豆霉素完全抑制了DNA修复合成。(ii) 还发现溴化乙锭、喹吖因和偏端霉素对修复有抑制作用,这些药物已知通过插入或结合DNA小沟来修饰DNA底物。(iii) 通过插入并同时结合可裂解的DNA-拓扑异构酶复合物起作用的抑制剂(m-AMSA、米托蒽醌、阿霉素和柔红霉素)也抑制了修复性DNA合成。(iv) 仅观察到依托泊苷、萘啶酸和恶喹酸有较小的作用,而替尼泊苷对DNA修复合成有显著抑制作用。(v) 美巴龙是一种新型拓扑异构酶II抑制剂,它能强烈阻断紫外线诱导的DNA修复。这些结果最好的解释是,在紫外线照射的人成纤维细胞中,180 kDa形式的拓扑异构酶II是抑制DNA切除修复的抑制剂的主要靶酶,并且这种同工酶参与修复特异性DNA切割之前的步骤。